Skip to content

Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya

Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02815579
Acronym
Shamba R01
Enrollment
746
Registered
2016-06-28
Start date
2016-06-30
Completion date
2019-12-31
Last updated
2024-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

HIV, Food insecurity, Microcredit loan, Agriculture, Livelihoods

Brief summary

The purpose of this study is to determine whether this multisectoral agricultural and microcredit loan intervention improves food security, prevent antiretroviral treatment failure, and reduce co-morbidities among people living with HIV/AIDS.

Detailed description

Despite major advances in care and treatment for those living with HIV, morbidity and mortality among people living with HIV/AIDS (PLHIV) remains unacceptably high in sub-Saharan Africa (SSA), largely due to the parallel challenges of poverty and food insecurity.\[1\] In the Nyanza Region of Kenya, 15.1% of the adult population is infected by HIV,\[2\] and over 50% of the rural population is food insecure, primarily due to unpredictable rainfall and limited irrigation.\[3,4\] The investigators have previously shown that food insecurity delays antiretroviral therapy (ART) initiation, reduces ART adherence, contributes to worse immunologic and virologic outcomes, and increases morbidity and mortality among PLHIV.\[5-16\] There has been increasing international recognition that improved food security and reduced poverty are essential components for a successful global response to the HIV epidemic.\[17-21\] Yet, to date few studies have systematically evaluated the impacts of sustainable food security interventions on health, economic, and behavioral outcomes among PLHIV. Agricultural interventions, which have potential to raise income and bolster food security, are an important but understudied route through which to sustainably improve nutritional and HIV outcomes in SSA, including Kenya where agriculture accounts for \> 75% of the total workforce, and 51% of the gross domestic product.\[22\] Building on the investigators successful completion of the pilot intervention trial in Kenya and the investigators collective experience studying structural barriers to HIV care in SSA, the investigators plan to test the hypothesis that a multisectoral agricultural and microcredit loan intervention will improve food security, prevent ART treatment failure, and reduce co-morbidities among PLHIV. The investigators' intervention was co-developed with KickStart, a prominent non-governmental organization (NGO) based in SSA that has introduced a human-powered pump, enabling farmers to grow high yield crops year-round. This technology has reduced food insecurity and poverty for 800,000 users in 22 countries in the subcontinent since 1991.\[23\] The investigators' intervention includes: a) a loan (\ $175) from a well-established Kenyan bank for purchasing agricultural implements and commodities; b) agricultural implements to be purchased with the loan including the KickStart treadle pump, seeds, fertilizers and pesticides; and c) education in financial management and sustainable farming practices occurring in the setting of patient support groups. This study is a cluster randomized controlled trial (RCT) of this intervention with the following specific aims: Aim 1: To determine the impact of a multisectoral agricultural intervention among HIV-infected farmers on ART on HIV clinical outcomes. The investigators hypothesize that the intervention will lead to improved viral load suppression (primary outcome) and changes in CD4 cell count, physical health status, WHO stage III/IV disease, and hospitalizations (secondary outcomes) in the intervention arm compared to the control arm. Aim 2: To understand the pathways through which the multisectoral intervention may improve HIV health outcomes. Using the investigator's theoretical model,\[1,24\] the investigators hypothesize that the intervention will improve food security and household wealth, which in turn will contribute to improved outcomes through nutritional (improved nutritional status measured with Body Mass Index), behavioral (improved ART adherence, and retention in care), and mental health (improved mental health/less depression, improved empowerment) pathways (secondary outcomes). Aim 3: To determine the cost-effectiveness of the intervention and obtain the information necessary to inform scale-up in Kenya and similar settings in SSA. The investigators will quantify the cost per disability-adjusted life year averted, and identify lessons to inform successful scale-up. To accomplish Aims 1 & 2, the investigators will randomize 8 matched pairs of health facilities in the Nyanza Region in a 1:1 ratio to the intervention and control arms, and enroll 44 participants per facility (total n=704). All participants will be followed for 2 years. Impacts of the investigator's intervention on primary health outcomes and mediators will be investigated to provide definitive data of direct and indirect intervention effects. To accomplish Aim 3, the investigators will: a) conduct a cost-effectiveness analysis; b) identify the characteristics of individuals most likely to benefit from the intervention (e.g., gender, educational attainment, family size, wealth, risk tolerance, and entrepreneurial ability); and c) perform a mixed-methods process evaluation with study participants, staff, and various stakeholders to determine what worked and did not work to guide future scale-up efforts of the intervention. The investigator's ultimate goal is to develop and test an intervention to reverse the cycle of food insecurity and HIV/AIDS morbidity and mortality in SSA.

Interventions

OTHERShamba Maisha Intervention

A) A loan (\ $175) B) Agricultural implements to be purchased with the loan C) Education in financial management and sustainable farming practices

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Kenya Medical Research Institute
CollaboratorOTHER
University of South Carolina
CollaboratorOTHER
University of Connecticut
CollaboratorOTHER
University of Pennsylvania
CollaboratorOTHER
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* HIV-infected adults * Currently receiving ART * Belong to a patient support group or demonstrate willingness to join a support group * Agree to save the down payment (\ $10) required for the microcredit loan * Have evidence of moderate to severe food insecurity based on the Household Food Insecurity Access Scale (HFIAS), and/or malnutrition (BMI\<18.5) based on FACES medical records during the year preceding recruitment * Have access to farming land and available surface water in the form of lakes, rivers, ponds and shallow wells

Exclusion criteria

* People who do not speak Dholuo, Swahili, or English * Inadequate cognitive and/or hearing capacity to complete planned study procedures, at the discretion of the research assistant

Design outcomes

Primary

MeasureTime frameDescription
Change in Proportion of Viral Load Suppression (<=200 Copies/mL)Baseline and endline (2 years after enrollment)The outcome was the change from baseline to the end of follow-up (2 years) in the proportion of participants in viral load suppression (≤200 copies/mL) compared between study groups using difference-in-differences analyses.

Secondary

MeasureTime frameDescription
Change (i.e. Linear Trend) in Mean Physical Health StatusBaseline and endline (2 years after enrollment)The outcome was the change (i.e. linear trend) from baseline to the end of follow-up (2 years) of the mean physical health score compared between study groups using the differences-in-differences analyses. We used the Medical Outcomes Study HIV Health Survey (MOS-HIV), a tool used to assess health-related quality of life that has been validated in resource-limited settings. Scores standardized to a range of 0 to 100. Higher scores mean a better outcome.
Change (i.e., Linear Trend) in the Proportion of Participants With AIDS-Defining ConditionBaseline and endline (2 years after enrollment)The outcome was the change (i.e., linear trend) from baseline to the end of follow-up (2 years) of the proportion of participants with an AIDS-defining condition, compared between study groups using difference-in-differences analyses. AIDS-defining conditions including HIV-related illnesses included in the Centers for Disease Control and Prevention's (CDC) list of diagnostic criteria for AIDS. AIDS-defining conditions include opportunistic infections and cancers that are life-threatening in a person with HIV.
Change (i.e., Linear Trend) in the Proportion of Participants Who Were Hospitalized in the Previous 6 MonthsBaseline and endline (2 years after enrollment)The outcome was the change (i.e. linear trend) from baseline to end of follow-up (2 years) of the proportion of participants hospitalized in the previous 6 months (yes/no), compared between study groups using difference-in-differences analyses.
Change (i.e. Linear Trend) in the Mean Score of Food Insecurity ScoreBaseline and endline (2 years after enrollment)The outcome was the change (i.e. linear trend) from baseline to the end of follow-up (2 years) of the mean household food insecurity score, compared between study groups using difference-in-differences analyses. using the Household Food Insecurity Access Scale (HFIAS). The HFIAS is a tool to assess household food insecurity (access). The scale scores range from 0 to 27, with higher scores indicating greater food insecurity.
Change (i.e., Linear Trend) in Proportion of Absolute CD4 Count <=500 Cells/mm^3Baseline and endline (2 years after enrollment)The outcome was the change (i.e., linear trend) from baseline to the end of follow-up (2 years) of the proportion of participants with a CD4 cell count \<=500 cells/mm\^3, compared between study groups using difference-in-differences analyses.
Change (i.e. Linear Trend) in Mean Self-reported Adherence to Antiretroviral TherapyBaseline and endline (2 years after enrollment)The outcome was the change (i.e. linear trend) from baseline to the end of follow-up (2 years) of the mean self-reported adherence to antiretroviral therapy compared between study groups using the differences-in-differences analyses.
Change (i.e. Linear Trend) in Mean Self-confidence ScoreBaseline and endline (2 years after enrollment)The outcome was the change (i.e. linear tend) from baseline to the end of follow-up (2 years) in the mean self-confidence score, compared between study groups using difference-in-differences analyses. Self-confidence is measured using the three-item Power Within scale, which has a range of 3 to 9 points where lower scores indicate greater self-confidence.
Change (i.e. Linear Trend) in Proportion of Probable DepressionBaseline and endline (2 years after enrollment)The outcome was the change (i.e. linear trend) from baseline to the end of follow-up (2 years) in the proportion with probable depression using the Hopkins Symptom Check-list for Depression, compared between study groups using difference-in-differences analyses.
Change (i.e. Linear Trend) in the Mean Internalized Stigma ScoreBaseline and endline (2 years after enrollment)The outcome was the change (i.e. linear trend) from baseline to the end of follow-up (2 years) in the mean internalized stigma score compared between study groups using the differences-in-differences analyses. Internalized HIV stigma arises when someone has accepted and endorsed the negative attitudes towards her/himself due to their HIV status. The internalized HIV stigma sub-scale consisted of six items asking respondents to agree with statements related to how they feel about being HIV positive, such as having HIV makes me feel like I'm a bad person and I feel ashamed of having HIV. Response options ranged from 1 strongly disagree to 5 strongly agree. During the analysis phase, the composite scores of each stigma sub-scale were rescaled to a row average of 1-5, with higher scores indicating greater stigma.
Change (i.e. Linear Trend) in Mean Nutritional Status (Represented by Body Mass Index (BMI))Baseline and endline (2 years after enrollment)The outcome was the change (i.e. linear trend) from baseline to the end of follow-up (2 years) of the mean body mass index (BMI) compared between study grouops using the differences-in-differences analyses.

Countries

Kenya

Participant flow

Participants by arm

ArmCount
Intervention
Participants received the multisectoral agricultural intervention.
366
Control
Participants in the control arm received the standard of care.
354
Total720

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath54
Overall StudyDid not meet enrollment criteria01
Overall StudyHospitalized before receipt of any study activities10
Overall StudyImprisoned02
Overall StudyLost to Follow-up74
Overall StudyMoved out of study area before receiving any study activities911
Overall StudyNon-payment of loan down-payment160
Overall StudyUncomfortable with MEMS adherence monitoring cap10
Overall StudyWithdrawal by Subject71

Baseline characteristics

CharacteristicControlInterventionTotal
Age, Continuous40.4 years
STANDARD_DEVIATION 9.3
40.3 years
STANDARD_DEVIATION 8.9
40.4 years
STANDARD_DEVIATION 9.1
BMI <18.5 kg/m^245 Participants41 Participants86 Participants
CD4+561 cells/mm^3
STANDARD_DEVIATION 235
603 cells/mm^3
STANDARD_DEVIATION 276
582 cells/mm^3
STANDARD_DEVIATION 257
Currently married251 Participants271 Participants522 Participants
Number of people in household6.1 people
STANDARD_DEVIATION 2.7
6.5 people
STANDARD_DEVIATION 2.6
6.3 people
STANDARD_DEVIATION 2.7
Race/Ethnicity, Customized
Black Kenyan
354 Participants366 Participants720 Participants
Region of Enrollment
Kenya
354 Participants366 Participants720 Participants
Religion
Catholic
353 Participants363 Participants716 Participants
Religion
Muslim
1 Participants0 Participants1 Participants
Religion
Other religion
0 Participants3 Participants3 Participants
Severely food insecure (vs. moderately)275 Participants293 Participants568 Participants
Sex: Female, Male
Female
194 Participants202 Participants396 Participants
Sex: Female, Male
Male
160 Participants164 Participants324 Participants
Viral load <=200 copies/mL291 Participants314 Participants605 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
5 / 3664 / 354
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Change in Proportion of Viral Load Suppression (<=200 Copies/mL)

The outcome was the change from baseline to the end of follow-up (2 years) in the proportion of participants in viral load suppression (≤200 copies/mL) compared between study groups using difference-in-differences analyses.

Time frame: Baseline and endline (2 years after enrollment)

Population: 677 participants who completed endline data collection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionChange in Proportion of Viral Load Suppression (<=200 Copies/mL)327 Participants
ControlChange in Proportion of Viral Load Suppression (<=200 Copies/mL)314 Participants
Comparison: The investigators produced a difference-in-difference estimate between baseline and year 2 using multi-level logistic regression. Units are in log odds.p-value: 0.8695% CI: [-1, 0.84]Mixed Models Analysis
Secondary

Change (i.e. Linear Trend) in Mean Nutritional Status (Represented by Body Mass Index (BMI))

The outcome was the change (i.e. linear trend) from baseline to the end of follow-up (2 years) of the mean body mass index (BMI) compared between study grouops using the differences-in-differences analyses.

Time frame: Baseline and endline (2 years after enrollment)

Population: 677 participants who completed endline data collection

ArmMeasureValue (MEAN)
InterventionChange (i.e. Linear Trend) in Mean Nutritional Status (Represented by Body Mass Index (BMI))22.1 kg/m^2
ControlChange (i.e. Linear Trend) in Mean Nutritional Status (Represented by Body Mass Index (BMI))21.8 kg/m^2
Comparison: The investigators analyzed longitudinal data measured every 6 months to assess trends in the two study arms and produced a difference-in-differences estimate between baseline and year 2.p-value: 0.0295% CI: [-0.39, -0.04]Mixed Models Analysis
Secondary

Change (i.e. Linear Trend) in Mean Physical Health Status

The outcome was the change (i.e. linear trend) from baseline to the end of follow-up (2 years) of the mean physical health score compared between study groups using the differences-in-differences analyses. We used the Medical Outcomes Study HIV Health Survey (MOS-HIV), a tool used to assess health-related quality of life that has been validated in resource-limited settings. Scores standardized to a range of 0 to 100. Higher scores mean a better outcome.

Time frame: Baseline and endline (2 years after enrollment)

Population: 677 participants who completed endline data collection

ArmMeasureValue (MEAN)
InterventionChange (i.e. Linear Trend) in Mean Physical Health Status86.0 units on a scale
ControlChange (i.e. Linear Trend) in Mean Physical Health Status86.2 units on a scale
Comparison: The investigators analyzed longitudinal data measured every 6 months to assess trends in the two study arms and produced a difference-in-differences estimate between baseline and year 2.p-value: 0.2695% CI: [-1.01, 3.78]Mixed Models Analysis
Secondary

Change (i.e. Linear Trend) in Mean Self-confidence Score

The outcome was the change (i.e. linear tend) from baseline to the end of follow-up (2 years) in the mean self-confidence score, compared between study groups using difference-in-differences analyses. Self-confidence is measured using the three-item Power Within scale, which has a range of 3 to 9 points where lower scores indicate greater self-confidence.

Time frame: Baseline and endline (2 years after enrollment)

Population: 677 participants who completed endline data collection

ArmMeasureValue (MEAN)
InterventionChange (i.e. Linear Trend) in Mean Self-confidence Score4.0 score on a scale
ControlChange (i.e. Linear Trend) in Mean Self-confidence Score4.0 score on a scale
Comparison: The investigators analyzed longitudinal data measured every 6 months to assess trends in the two study arms and produced a difference-in-differences estimate between baseline and year 2.p-value: 0.00195% CI: [-0.59, -0.15]Mixed Models Analysis
Secondary

Change (i.e. Linear Trend) in Mean Self-reported Adherence to Antiretroviral Therapy

The outcome was the change (i.e. linear trend) from baseline to the end of follow-up (2 years) of the mean self-reported adherence to antiretroviral therapy compared between study groups using the differences-in-differences analyses.

Time frame: Baseline and endline (2 years after enrollment)

Population: 677 participants who completed endline data collection

ArmMeasureValue (MEAN)
InterventionChange (i.e. Linear Trend) in Mean Self-reported Adherence to Antiretroviral Therapy100 percentage of doses taken
ControlChange (i.e. Linear Trend) in Mean Self-reported Adherence to Antiretroviral Therapy100 percentage of doses taken
Comparison: The investigators analyzed longitudinal data measured every 6 months to assess trends in the two study arms and produced a difference-in-differences estimate between baseline and year 2.p-value: 0.9895% CI: [-0.82, 0.84]Mixed Models Analysis
Secondary

Change (i.e., Linear Trend) in Proportion of Absolute CD4 Count <=500 Cells/mm^3

The outcome was the change (i.e., linear trend) from baseline to the end of follow-up (2 years) of the proportion of participants with a CD4 cell count \<=500 cells/mm\^3, compared between study groups using difference-in-differences analyses.

Time frame: Baseline and endline (2 years after enrollment)

Population: 677 participants who completed endline data collection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionChange (i.e., Linear Trend) in Proportion of Absolute CD4 Count <=500 Cells/mm^3128 Participants
ControlChange (i.e., Linear Trend) in Proportion of Absolute CD4 Count <=500 Cells/mm^3129 Participants
Comparison: The investigators analyzed longitudinal data measured every 6 months to assess trends in the two study arms and produced a difference-in-differences estimate between baseline and year 2 using multi-level logistic regression. Units are in log odds.p-value: 0.2395% CI: [-0.28, 0.92]Mixed Models Analysis
Secondary

Change (i.e. Linear Trend) in Proportion of Probable Depression

The outcome was the change (i.e. linear trend) from baseline to the end of follow-up (2 years) in the proportion with probable depression using the Hopkins Symptom Check-list for Depression, compared between study groups using difference-in-differences analyses.

Time frame: Baseline and endline (2 years after enrollment)

Population: 677 participants who completed endline data collection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionChange (i.e. Linear Trend) in Proportion of Probable Depression36 Participants
ControlChange (i.e. Linear Trend) in Proportion of Probable Depression41 Participants
Comparison: The investigators analyzed longitudinal data measured every 6 months to assess trends in the two study arms and produced a difference-in-differences estimate between baseline and year 2 using multi-level logistic regression. Units are in log odds.p-value: 0.00195% CI: [-1.45, -0.2]Mixed Models Analysis
Secondary

Change (i.e. Linear Trend) in the Mean Internalized Stigma Score

The outcome was the change (i.e. linear trend) from baseline to the end of follow-up (2 years) in the mean internalized stigma score compared between study groups using the differences-in-differences analyses. Internalized HIV stigma arises when someone has accepted and endorsed the negative attitudes towards her/himself due to their HIV status. The internalized HIV stigma sub-scale consisted of six items asking respondents to agree with statements related to how they feel about being HIV positive, such as having HIV makes me feel like I'm a bad person and I feel ashamed of having HIV. Response options ranged from 1 strongly disagree to 5 strongly agree. During the analysis phase, the composite scores of each stigma sub-scale were rescaled to a row average of 1-5, with higher scores indicating greater stigma.

Time frame: Baseline and endline (2 years after enrollment)

ArmMeasureValue (MEAN)Dispersion
InterventionChange (i.e. Linear Trend) in the Mean Internalized Stigma Score1.40 units on a scaleStandard Deviation 0.68
ControlChange (i.e. Linear Trend) in the Mean Internalized Stigma Score1.72 units on a scaleStandard Deviation 0.71
p-value: <0.00195% CI: [-0.52, -0.31]Mixed Models Analysis
Secondary

Change (i.e. Linear Trend) in the Mean Score of Food Insecurity Score

The outcome was the change (i.e. linear trend) from baseline to the end of follow-up (2 years) of the mean household food insecurity score, compared between study groups using difference-in-differences analyses. using the Household Food Insecurity Access Scale (HFIAS). The HFIAS is a tool to assess household food insecurity (access). The scale scores range from 0 to 27, with higher scores indicating greater food insecurity.

Time frame: Baseline and endline (2 years after enrollment)

Population: 677 participants who completed endline data collection

ArmMeasureValue (MEAN)
InterventionChange (i.e. Linear Trend) in the Mean Score of Food Insecurity Score14.0 score on a scale
ControlChange (i.e. Linear Trend) in the Mean Score of Food Insecurity Score15.0 score on a scale
Comparison: The investigators analyzed longitudinal data measured every 6 months to assess trends in the two study arms and produced a difference-in-differences estimate between baseline and year 2.p-value: <0.00195% CI: [-4.16, -2.92]Mixed Models Analysis
Secondary

Change (i.e., Linear Trend) in the Proportion of Participants Who Were Hospitalized in the Previous 6 Months

The outcome was the change (i.e. linear trend) from baseline to end of follow-up (2 years) of the proportion of participants hospitalized in the previous 6 months (yes/no), compared between study groups using difference-in-differences analyses.

Time frame: Baseline and endline (2 years after enrollment)

Population: 677 participants who completed endline data collection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionChange (i.e., Linear Trend) in the Proportion of Participants Who Were Hospitalized in the Previous 6 Months21 Participants
ControlChange (i.e., Linear Trend) in the Proportion of Participants Who Were Hospitalized in the Previous 6 Months18 Participants
Comparison: The investigators analyzed longitudinal data measured every 6 months to assess trends in the two study arms and produced a difference-in-differences estimate between baseline and year 2 using multi-level logistic regression. Units are in log odds.p-value: 0.4495% CI: [-1.22, 0.53]Mixed Models Analysis
Secondary

Change (i.e., Linear Trend) in the Proportion of Participants With AIDS-Defining Condition

The outcome was the change (i.e., linear trend) from baseline to the end of follow-up (2 years) of the proportion of participants with an AIDS-defining condition, compared between study groups using difference-in-differences analyses. AIDS-defining conditions including HIV-related illnesses included in the Centers for Disease Control and Prevention's (CDC) list of diagnostic criteria for AIDS. AIDS-defining conditions include opportunistic infections and cancers that are life-threatening in a person with HIV.

Time frame: Baseline and endline (2 years after enrollment)

Population: 677 participants who completed endline data collection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionChange (i.e., Linear Trend) in the Proportion of Participants With AIDS-Defining Condition4 Participants
ControlChange (i.e., Linear Trend) in the Proportion of Participants With AIDS-Defining Condition2 Participants
Comparison: The investigators analyzed longitudinal data measured every 6 months to assess trends in the two study arms and produced a difference-in-differences estimate between baseline and year 2 using multi-level logistic regression. Units are in log odds.p-value: 0.3195% CI: [-0.79, 2.47]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: May 10, 2026